Shaghayegh Shahrigharahkoshan; Fariba Ghalamkarpour; Mohammadhossein Ghasempourabadi; Fahimeh Abdollahimajd
Abstract
The coronavirus disease 2019 (COVID-19) pandemic, the scale of its damage to all sectors, and its high rate of mortality urgently called all scientists and researchers into action to find solutions that can mitigate its multi-dimensional burden. As of October 1st, 2021, COVID-19 has claimed more than ...
Read More
The coronavirus disease 2019 (COVID-19) pandemic, the scale of its damage to all sectors, and its high rate of mortality urgently called all scientists and researchers into action to find solutions that can mitigate its multi-dimensional burden. As of October 1st, 2021, COVID-19 has claimed more than 4.5 million lives and infected more than 200 million individuals. Therefore, every small effort that can positively contribute to the alleviation of the disease and its spread can tremendously help minimize the damage. The application of light as a therapeutic agent has been effective since the beginning of civilization. During the last century, artificial light and its combination with other chemical substances to fight microorganisms have been applied substantially in many domains, such as therapeutics and immunomodulation. In this review, we present the scalable application of light as an antimicrobial and immunomodulatory agent and its potential in fighting COVID-19 and in mitigating its damages by representing the recent developments in this area.
Alireza Khatami; Pegeen Walsh
Abstract
The World Health Organization characterized the outbreak of the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), as a pandemic on March 11, 2020. According to official reports, over 12,300,000 individuals have caught the disease globally ...
Read More
The World Health Organization characterized the outbreak of the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), as a pandemic on March 11, 2020. According to official reports, over 12,300,000 individuals have caught the disease globally over the past six months. Like many other professions, the disease has affected private and academic dermatology practices around the world. The disease has diverse and extensive skin manifestations with implications for dermatology education and research. Some other issues that may concern dermatologists during the pandemic include ethics pertaining to the optimal use of scarce resources like certain drugs and personal protective equipment as well as surcharging patients and the potential of increasing the size of the preexisting health inequity gap. Considering all these issues, discussing the ethical aspects of dermatology, i.e., dermatoethics, during this pandemic is critical. Herein, we review the four basic biomedical ethics principles of autonomy, beneficence, non-maleficence, and justice in the context of the COVID-19 pandemic.
Mohammad Shahidi Dadras; Sahar Dadkhahfar; Ayda Bahmanjahromi; Hannane Seifian; Fahimeh Abdollahimajd
Abstract
The coronavirus disease 2019 (COVID-19) has emerged as a worldwide pandemic. In addition to pulmonary symptoms, reports of the involvement of other organs such as the skin are being published. We present the cases of three COVID-19 patients who presented with cutaneous manifestations ...
Read More
The coronavirus disease 2019 (COVID-19) has emerged as a worldwide pandemic. In addition to pulmonary symptoms, reports of the involvement of other organs such as the skin are being published. We present the cases of three COVID-19 patients who presented with cutaneous manifestations and review the previous reports. Purpura and petechiae, erythematous papules andmacules, and urticarial eruptions are signs seen in the presented cases. Although a growing number of cutaneous manifestations of COVID-19 have been reported, there is no doubt that further reports of both typical and atypical presentations are needed to confirm and understand skin involvement in COVID-19. Since COVID-19 manifests in various forms, dermatologists, as thefirst line of dealing with patients who come with skin rashes, should always be aware of the early diagnosis of this disease.
